Jan 6, 2023 07:02AM
Jan 6, 2023 07:01AM
Nov 28, 2022 07:02AM
Nov 28, 2022 07:01AM
Nov 10, 2022 04:01PM
Nov 7, 2022 07:01AM
Sep 15, 2022 07:01AM Nabriva (NBRV) Announces September 16 as Date of 1:25 Reverse Stock Split
Sep 15, 2022 07:01AM
Aug 11, 2022 07:01AM
Aug 3, 2022 04:01PM
Jul 20, 2022 04:05PM
Jul 18, 2022 07:02AM
Jul 18, 2022 07:01AM
May 5, 2022 04:01PM Nabriva Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
May 5, 2022 07:01AM
May 5, 2022 07:01AM
May 2, 2022 04:05PM
Apr 11, 2022 04:05PM
Mar 29, 2022 04:01PM
Mar 15, 2022 07:01AM
Jan 10, 2022 07:00AM Nabriva Therapeutics Provides Business Update and Announces Preliminary Financial Results for the Fourth Quarter of 2021
Nov 11, 2021 07:01AM
Nov 11, 2021 07:01AM
Nov 9, 2021 04:01PM
Oct 4, 2021 04:07PM
Oct 4, 2021 04:05PM
Aug 5, 2021 04:01PM
Aug 5, 2021 08:00AM Acurx Pharmaceuticals Joins the Antimicrobials Working Group
Jun 8, 2021 11:18AM
May 26, 2021 09:23AM
May 25, 2021 05:02PM
May 25, 2021 05:00PM
May 6, 2021 04:01PM
Apr 29, 2021 04:05PM
Apr 15, 2021 12:12PM Nabriva Commences Exclusive Distribution of SIVEXTRO® (tedizolid phosphate) in the U.S.
Apr 12, 2021 04:00AM
Mar 16, 2021 08:13AM
Mar 16, 2021 08:00AM
Mar 11, 2021 04:07PM
Mar 3, 2021 04:05PM
Feb 26, 2021 08:04AM
Feb 26, 2021 08:00AM Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer
Feb 23, 2021 07:06AM
Feb 23, 2021 07:00AM
Feb 17, 2021 10:04AM
Feb 1, 2021 04:33PM
Feb 1, 2021 04:30PM
Dec 11, 2020 09:30AM
Dec 7, 2020 07:03AM Nabriva (NBRV) and Sinovant Sciences Restructure License Agreement for XENLETA for Community-Acquired Bacterial Pneumonia in China
Dec 7, 2020 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All